Novartis AG (SWX:NOVN)
Switzerland
· Delayed Price · Currency is CHF 98.40
+0.40 (0.41%)
Sep 26, 2025, 5:31 PM CET
Novartis AG Employees
Novartis AG had 75,883 employees as of December 31, 2024. The number of employees decreased by 174 or -0.23% compared to the previous year.
Employees
75,883
Change (1Y)
-174
Growth (1Y)
-0.23%
Revenue / Employee
578.37K CHF
Profits / Employee
143.10K CHF
Market Cap
190.49B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 75,883 | -174 | -0.23% |
| Dec 31, 2023 | 76,057 | -25,646 | -25.22% |
| Dec 31, 2022 | 101,703 | -2,620 | -2.51% |
| Dec 31, 2021 | 104,323 | -1,471 | -1.39% |
| Dec 31, 2020 | 105,794 | 1,880 | 1.81% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Lonza Group AG | 18,944 |
| Galderma Group AG | 6,545 |
| Alcon | 25,599 |
| Sandoz Group AG | 22,049 |
| Straumann Holding AG | 11,815 |
| Sonova Holding AG | 18,366 |
| Ypsomed Holding AG | 2,644 |
Novartis AG News
- 3 days ago - Novartis to showcase transformative data in advanced prostate and early breast cancer at ESMO 2025 - GlobeNewsWire
- 3 days ago - DFIV, B, TD, NVS: Large Inflows Detected at ETF - Nasdaq
- 5 days ago - New Novartis data further support benefits of Kesimpta® in relapsing MS following switch from oral disease modifying therapies - GlobeNewsWire
- 5 days ago - A Nobel Prize? How Big Pharma is trying to appease Trump - EURACTIV.com
- 6 days ago - Novartis Builds US Drug Reserves Against Potential Tariffs - Benzinga
- 7 days ago - Novartis (NVS) Boosts U.S. Pharmaceutical Inventory Amid Tariff Concerns - GuruFocus
- 7 days ago - Novartis (NVS) CEO Discusses Potential U.S. Price Reductions - GuruFocus
- 8 days ago - Novartis ramps up US stockpiles to shield against potential tariffs - Invezz